Population Health Sciences

You are here

Publications

Found 311 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
Journal Article
Krebs E, Enns B, Wang L, Zang X, Panagiotoglou D, Del Rio C, Dombrowski J, Feaster DJ, Golden M, Granich R et al..  2019.  Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis.. PLoS One. 14(5):e0217559.
Krebs E, Enns B, Wang L, Zang X, Panagiotoglou D, Del Rio C, Dombrowski J, Feaster DJ, Golden M, Granich R et al..  2019.  Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis.. PLoS One. 14(5):e0217559.
Krebs E, Enns B, Wang L, Zang X, Panagiotoglou D, Del Rio C, Dombrowski J, Feaster DJ, Golden M, Granich R et al..  2019.  Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis.. PLoS One. 14(5):e0217559.
Sharma H, Mao C, Zhang Y, Vatani H, Yao L, Zhong Y, Rasmussen L, Jiang G, Pathak J, Luo Y.  2019.  Developing a portable natural language processing based phenotyping system.. BMC Med Inform Decis Mak. 19(Suppl 3):78.
Liu J, Westblade LF, Wang F, Chadburn A, Fideli R, Craney A, Rand S, Cushing MM, Meng J, Zhao Z et al..  2022.  Distinct Laboratory Test Result Profiles Between SARS-CoV-2 and Seasonable Influenza Infected Patients.. Ann Clin Lab Sci. 52(6):871-879.
Bishop TF, Ryan MSmith, McCullough CM, Shih SC, Casalino LP, Ryan AM.  2015.  Do provider attitudes about electronic health records predict future electronic health record use? Healthc (Amst). 3(1):5-11.
Ghomrawi HMK, Mancuso CA, Dunning A, Valle AGonzalez D, Alexiades M, Cornell C, Sculco T, Bostrom M, Mayman D, Marx RG et al..  2017.  Do Surgeon Expectations Predict Clinically Important Improvements in WOMAC Scores After THA and TKA? Clin Orthop Relat Res. 475(9):2150-2158.
Ghomrawi HMK, Mancuso CA, Dunning A, Valle AGonzalez D, Alexiades M, Cornell C, Sculco T, Bostrom M, Mayman D, Marx RG et al..  2017.  Do Surgeon Expectations Predict Clinically Important Improvements in WOMAC Scores After THA and TKA? Clin Orthop Relat Res. 475(9):2150-2158.
Ghomrawi HMK, Mancuso CA, Dunning A, Valle AGonzalez D, Alexiades M, Cornell C, Sculco T, Bostrom M, Mayman D, Marx RG et al..  2017.  Do Surgeon Expectations Predict Clinically Important Improvements in WOMAC Scores After THA and TKA? Clin Orthop Relat Res. 475(9):2150-2158.
Ghomrawi HMK, Mancuso CA, Dunning A, Valle AGonzalez D, Alexiades M, Cornell C, Sculco T, Bostrom M, Mayman D, Marx RG et al..  2017.  Do Surgeon Expectations Predict Clinically Important Improvements in WOMAC Scores After THA and TKA? Clin Orthop Relat Res. 475(9):2150-2158.
Jung H-Y, Trivedi AN, Grabowski DC, Mor V.  2016.  Does More Therapy in Skilled Nursing Facilities Lead to Better Outcomes in Patients With Hip Fracture? Phys Ther. 96(1):81-9.
Ancker JS, Mauer E, Kalish RB, Vest JR, J Gossey T.  2019.  Early Adopters of Patient-Generated Health Data Upload in an Electronic Patient Portal.. Appl Clin Inform. 10(2):254-260.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Jalali A, Ryan DA, McCollister KE, Marsch LA, Schackman BR, Murphy SM.  2020.  Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.. J Subst Abuse Treat. 112S:18-27.
Jalali A, Ryan DA, McCollister KE, Marsch LA, Schackman BR, Murphy SM.  2020.  Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.. J Subst Abuse Treat. 112S:18-27.
Jalali A, Ryan DA, McCollister KE, Marsch LA, Schackman BR, Murphy SM.  2020.  Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.. J Subst Abuse Treat. 112S:18-27.
Flory JH, Mushlin AI.  2020.  Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes.. Diabetes Care.
Navathe AS, Volpp KG, Caldarella KL, Bond A, Troxel AB, Zhu J, Matloubieh S, Lyon Z, Mishra A, Sacks L et al..  2019.  Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study.. JAMA Netw Open. 2(2):e187950.
Navathe AS, Volpp KG, Caldarella KL, Bond A, Troxel AB, Zhu J, Matloubieh S, Lyon Z, Mishra A, Sacks L et al..  2019.  Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study.. JAMA Netw Open. 2(2):e187950.
Navathe AS, Volpp KG, Caldarella KL, Bond A, Troxel AB, Zhu J, Matloubieh S, Lyon Z, Mishra A, Sacks L et al..  2019.  Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study.. JAMA Netw Open. 2(2):e187950.
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..  2020.  Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..  2020.  Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..  2020.  Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..  2020.  Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..  2020.  Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.